Obesity medication Zepbound will be available to buy in 2.5-milligram and 5-milligram single-dose vials on manufacturer Eli Lilly's telehealth...

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Does Eli Lilly (LLY) have what it takes to be a top stock pick for momentum investors? Let's find out.

Eli Lilly and Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome...

Eli Lilly and Co. is now selling vials of its blockbuster weight-loss drug Zepbound to patients for as little as $399 a month as it works to overcome...

LLY's single-dose vials are priced at least 50% lower than the list price of all other GLP-1 medicines for obesity.

INDIANAPOLIS, Aug. 27, 2024 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced Zepbound® (tirzepatide) 2.5 mg and 5 mg single-dose...

Eli Lilly will now sell cheaper vials of Zepbound, presenting a direct challenge to telehealth companies that offer compounded versions of the...

LLY launches a discounted version of Zepbound. European Commission approves JNJ's Balversa, MRK's Winrevair and RHHBY's PiaSky.

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim,...